MAP
GOSS icon

Madison Avenue Partners’s Gossamer Bio GOSS Stock Holding History

Madison Avenue Partners’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-4,140,773
Closed -$4.89M – 21
2024
Q1 		$4.89M Sell
4,140,773
-913,699
-18% -$1.01M 0.79% 15
2023
Q4 		$4.61M Sell
5,054,472
-1,075,796
-18% -$795K 0.65% 15
2023
Q3 		$5.11M Buy
+6,130,268
New +$7.06M 0.72% 13
2023
Q1 		– Sell
-711,178
Closed -$1.54M – 21
2022
Q4 		$1.54M Sell
711,178
-675,784
-49% -$5.56M 0.27% 20
2022
Q3 		$16.6M Buy
+1,386,962
New +$17.2M 3.56% 9

Other funds holding GOSS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Madison Avenue Partners's GOSS Position: Q2 2024 in Review

Madison Avenue Partners sold out of Gossamer Bio (GOSS) in Q2 2024, closing a stake of 4,140,773 shares — an estimated $4.89M sold.

Madison Avenue Partners first reported a position in GOSS in Q3 2022 and held it in 5 quarters. The position peaked at $16.6M in Q3 2022. 94 funds tracked by Wall St. Rank hold GOSS as of Q2 2024.

  • Madison Avenue Partners reported no remaining Gossamer Bio position as of Q2 2024 after selling out during the quarter.
  • Madison Avenue Partners sold 4,140,773 Gossamer Bio shares in Q2 2024, an estimated $4.89M.
  • Madison Avenue Partners first reported a position in Gossamer Bio in Q3 2022 and held it in 5 quarters.
  • Madison Avenue Partners's Gossamer Bio position peaked at $16.6M in Q3 2022.
  • 94 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2024.

Based on Madison Avenue Partners's 13F filing for Q2 2024, filed 14 Aug 2024.